Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

PJ Woll, P Reichardt, A le Cesne, S Bonvalot, A Azzarelli, HJ Hoekstra, M Leahy, F van Coevorden, Jaap Verweij, PCW Hogendoorn, M Ouali, S Marreaud, VHC Bramwell, P Hohenberger

Research output: Contribution to journalArticleAcademicpeer-review

318 Citations (Scopus)

Abstract

Background The effect of adjuvant chemotherapy on survival for resected soft-tissue sarcoma remains unknown. We investigated the effect of intensive adjuvant chemotherapy on survival in patients after resection of high-risk soft-tissue sarcomas. Methods In this multicentre randomised trial, patients with macroscopically resected, Trojani grade II-III soft-tissue sarcomas at any site, no metastases, performance status lower than 2 and aged between 16 and 70 years were eligible within 4 weeks of definitive surgery. Patients were randomly assigned to receive adjuvant chemotherapy or no chemotherapy (control group). Randomisation was done with a minimisation technique, stratified by hospital, site of primary tumour, tumour size, planned rad Findings Between February, 1995, and December, 2003, 351 patients were randomly assigned to the adjuvant chemotherapy group (175 patients) or to the control group (176). 258 (73%) of 351 patients received radiotherapy, 129 in each group. Overall survival did not differ significantly between groups (hazard ratio [HR] 0.94 [95% CI 0.68-1.31], p=0.72) nor did relapse-free survival (HR 0.91 [0.67-1.22], p=0.51). 5-year overall survival rate was 66.5% (58.8-73.0) in the chemotherapy group and 67.8% ( Interpretation Adjuvant chemotherapy with doxorubicin and ifosfamide in resected soft-tissue sarcoma showed no benefit in relapse-free survival or overall survival. Future studies should focus on patients with larger, grade III, and extremity sarcomas.
Original languageUndefined/Unknown
Pages (from-to)1045-1054
Number of pages10
JournalLancet Oncology
Volume13
Issue number10
DOIs
Publication statusPublished - 2012

Cite this